Put Options

13 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 15, 2023

BUY
$1.46 - $7.3 $174,616 - $873,080
119,600 New
119,600 $190,000
Q2 2022

Aug 15, 2022

BUY
$4.77 - $6.67 $119,249 - $166,750
25,000 New
25,000 $159,000
Q4 2021

Feb 11, 2022

SELL
$4.81 - $11.92 $72,150 - $178,800
-15,000 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$11.34 - $21.37 $1.42 Million - $2.68 Million
-125,300 Reduced 89.31%
15,000 $181,000
Q2 2021

Aug 16, 2021

BUY
$19.4 - $28.71 $345,320 - $511,038
17,800 Added 14.53%
140,300 $2.97 Million
Q1 2021

May 17, 2021

BUY
$25.12 - $36.89 $3.08 Million - $4.52 Million
122,500 New
122,500 $3.44 Million
Q4 2020

Feb 16, 2021

SELL
$24.2 - $35.76 $363,000 - $536,400
-15,000 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$30.04 - $51.31 $360,480 - $615,720
-12,000 Reduced 44.44%
15,000 $770,000
Q1 2020

May 15, 2020

SELL
$27.44 - $73.84 $82,320 - $221,520
-3,000 Reduced 10.0%
27,000 $852,000
Q2 2019

Aug 13, 2019

BUY
$40.1 - $52.33 $1.2 Million - $1.57 Million
30,000 New
30,000 $1.4 Million
Q1 2019

May 14, 2019

SELL
$40.11 - $53.57 $1.7 Million - $2.28 Million
-42,500 Closed
0 $0
Q4 2018

Jan 30, 2019

SELL
$36.99 - $59.11 $3.98 Million - $6.35 Million
-107,500 Reduced 71.67%
42,500 $1.96 Million
Q3 2018

Nov 14, 2018

BUY
$40.74 - $51.41 $6.11 Million - $7.71 Million
150,000 New
150,000 $6.66 Million

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $146M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.